Download
13005_2024_Article_428.pdf 1,78MB
WeightNameValue
1000 Titel
  • Halitosis in young patients with chronic kidney disease: findings from a randomized controlled trial
1000 Autor/in
  1. Hoefer, Karolin Charlotte |
  2. Barbe, Anna Greta |
  3. Adams, Anne |
  4. Schoppmeier, Christoph |
  5. Wicht, Michael Jochen |
  6. Weber, Lutz T |
  7. Noack, Michael J |
  8. Graf, Isabelle |
1000 Verlag BioMed Central
1000 Erscheinungsjahr 2024
1000 Publikationstyp
  1. Artikel |
1000 Online veröffentlicht
  • 2024-05-15
1000 Erschienen in
1000 Quellenangabe
  • 20(1):32
1000 Copyrightjahr
  • 2024
1000 Lizenz
1000 Verlagsversion
  • https://doi.org/10.1186/s13005-024-00428-y |
  • https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11094915/ |
1000 Publikationsstatus
1000 Begutachtungsstatus
1000 Sprache der Publikation
1000 Abstract/Summary
  • <jats:title>Abstract</jats:title><jats:sec> <jats:title>Background</jats:title> <jats:p>Chronic kidney disease (CKD) directly affects oral health. Yet data about halitosis in young CKD patients and the impact of dental prophylaxis is limited. Therefore, as part of this randomized clinical trial, halitosis in young CKD patients undergoing intensive or standard oral preventive procedures was to be explored.</jats:p> </jats:sec><jats:sec> <jats:title>Methods</jats:title> <jats:p>Three volatile sulfur compounds (hydrogen sulfide, methyl mercaptan and dimethyl sulfide) were measured in 30 young patients with CKD (mean age 14.2 years; 16 males, 14 females). Breath samples were taken after 3 and 6 months and analyzed with selective gas chromatography (OralChroma). Tongue coating (Winkel Index) and clinical indices to determine local inflammation or oral hygiene (Papillary Bleeding Index and Quigley-Hein Index) were assessed. Within an extended anamnesis, patients and their mothers and nurses were questioned about the perceived halitosis. Corresponding quotes were noted verbatim. Patients were randomized to either intensive need-related oral health care measures (oral preventative program, OPP) or a one-stage standard prevention (treatment as usual, TAU).</jats:p> </jats:sec><jats:sec> <jats:title>Results</jats:title> <jats:p>While there were no differences in volatile sulfur compound levels between TAU and OPP at the three time points of measurements (<jats:italic>p</jats:italic> &gt; 0.05), there was a tendency towards a reduction in dimethyl sulfide and hydrogen sulfide of affected patients within the OPP group over time. Looking at potential differences between both groups with regard to tongue coating, significant differences were observed between baseline and 3 months after study start in the OPP group, and between baseline and 6 months after study start in the TAU group (<jats:italic>p</jats:italic> &lt; 0.05). The burden of halitosis was frequently reported by patients’ mothers and nurses.</jats:p> </jats:sec><jats:sec> <jats:title>Conclusions</jats:title> <jats:p>Young CKD patients regularly suffered from halitosis and dimethyl sulfide was its main source. Preventive measures mainly resulted in a reduction of tongue coating. Trial registration: The German Clinical Trial Register (# DRKS00010580).</jats:p> </jats:sec>
1000 Sacherschließung
lokal Adolescent [MeSH]
lokal Female [MeSH]
lokal Hydrogen Sulfide [MeSH]
lokal Adolescents
lokal Halitosis/etiology [MeSH]
lokal Humans [MeSH]
lokal Sulfur Compounds/analysis [MeSH]
lokal Renal Insufficiency, Chronic/complications [MeSH]
lokal Halitosis/prevention
lokal Breath Tests/methods [MeSH]
lokal Male [MeSH]
lokal Children
lokal Research
lokal Oral Hygiene [MeSH]
lokal Chronic kidney disease
lokal Halitosis
lokal Chromatography, Gas/methods [MeSH]
lokal Child [MeSH]
1000 Fächerklassifikation (DDC)
1000 Liste der Beteiligten
  1. https://frl.publisso.de/adhoc/uri/SG9lZmVyLCBLYXJvbGluIENoYXJsb3R0ZQ==|https://frl.publisso.de/adhoc/uri/QmFyYmUsIEFubmEgR3JldGE=|https://frl.publisso.de/adhoc/uri/QWRhbXMsIEFubmU=|https://frl.publisso.de/adhoc/uri/U2Nob3BwbWVpZXIsIENocmlzdG9waA==|https://frl.publisso.de/adhoc/uri/V2ljaHQsIE1pY2hhZWwgSm9jaGVu|https://frl.publisso.de/adhoc/uri/V2ViZXIsIEx1dHogVA==|https://frl.publisso.de/adhoc/uri/Tm9hY2ssIE1pY2hhZWwgSg==|https://frl.publisso.de/adhoc/uri/R3JhZiwgSXNhYmVsbGU=
1000 Hinweis
  • DeepGreen-ID: 3bb691b2f3674b6b971b15590a973802 ; metadata provieded by: DeepGreen (https://www.oa-deepgreen.de/api/v1/), LIVIVO search scope life sciences (http://z3950.zbmed.de:6210/livivo), Crossref Unified Resource API (https://api.crossref.org/swagger-ui/index.html), to.science.api (https://frl.publisso.de/), ZDB JSON-API (beta) (https://zeitschriftendatenbank.de/api/), lobid - Dateninfrastruktur für Bibliotheken (https://lobid.org/resources/search)
1000 Label
1000 Förderer
  1. Universitätsklinikum Köln |
1000 Fördernummer
  1. -
1000 Förderprogramm
  1. -
1000 Dateien
1000 Förderung
  1. 1000 joinedFunding-child
    1000 Förderer Universitätsklinikum Köln |
    1000 Förderprogramm -
    1000 Fördernummer -
1000 Objektart article
1000 Beschrieben durch
1000 @id frl:6518771.rdf
1000 Erstellt am 2025-07-05T13:29:47.658+0200
1000 Erstellt von 322
1000 beschreibt frl:6518771
1000 Zuletzt bearbeitet 2025-08-15T20:55:46.361+0200
1000 Objekt bearb. Fri Aug 15 20:55:46 CEST 2025
1000 Vgl. frl:6518771
1000 Oai Id
  1. oai:frl.publisso.de:frl:6518771 |
1000 Sichtbarkeit Metadaten public
1000 Sichtbarkeit Daten public
1000 Gegenstand von

View source